 |
Selected reference cases:
- Invalidation of a European Patent as a strategic
consultant to a French biotechnology company.
- Advice to investor in market and technology analysis.
- Negotiation and closing of an exclusive license
contract for the percutaneously implantable and
self-expandable ECP blood pump of AIS GmbH Aachen
Innovative Systems, Germany.
- Negotiation and closing of the sale of AIS GmbH Aachen
Innovative Systems, Germany, to Abiomed, Inc., USA.
- Development of business plans for German medical
device companies.
- Development of business plan for a German biopharma
start-up company.
|
|
|
|
- Development of business plan and investment case and
spin off of the medtech company MaRVis
Interventional GmbH. Operative, technology, IP and
corporate development as CEO. MaRVis has developed a
platform technology for MR safe and visible medical
devices with a focus on guidewires. The products bear
the CE Mark and are commercialized.
- Subsequent to initially internal project development
spin off of the medtech company Alaxo
GmbH. Alaxo has developed the first reusable
stents (AlaxoLito Nasal Stents and Alaxo Hybrid Stent)
for mechanical splinting of the upper airway. The
products are approved as medical devices in Europe and
USA and sold in several regions of the world. Alaxo
possesses specialized manufacturing know how and
equipment for its proprietary products. Operative
company management as CEO.
- Patent protection (WO 2016062665 A2) and development
of a novel braided venous stent with a segmented
braiding pattern plus a novel stent deployment system
with repositioning functionality. Prototype development
and testing.
|
|
